http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0806154-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aac4a747e60a2949ac458ccdbb76fdea |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-432 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-602 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-915 |
filingDate | 2008-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46f83a23276ac294c4d9bc443c054bdc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_505999c62bfcdece996ca126e8e63369 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d43f27be30923d262037c05c3d1a8715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84c785aa07ec3fbb3d8ead941a641fc1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_306a212ff074458afe717a5b3d5e167d |
publicationDate | 2010-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | BR-PI0806154-A2 |
titleOfInvention | local vascular release of mtor inhibitors in combination with peroxisome proliferator-activated receptor stimulators |
abstract | LOCAL VASCULAR RELEASE OF mTOR INHIBITORS IN COMBINATION WITH RECIPIENT STIMULATORS ACTIVATED BY PEROXISSOM PROLIFERATORS. The present invention relates to medical devices, and in particular implantable medical devices, which may be coated to minimize or substantially eliminate an organism biological reaction to the introduction of the medical device into the organism. Medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and attached to at least a portion of the medical device. These therapeutic agents or compounds may also further reduce an organism's biological reaction to the introduction of the medical device into the organism. In addition, these therapeutic drugs, agents and / or compounds may be used to promote healing, including the prevention of thrombosis. Drugs, agents, and / or compounds may also be used to treat specific disorders, including vulnerable plaque, and atherosclerosis in type 2 diabetic patients. Therapeutic agents may also be released to the region of a disease site. In regional release, liquid formulations may be desirable to increase the efficacy and release ability of the particular drug. In addition, the devices may be modified to promote endothelialization. Various coating materials and methodologies may be used to hold agents or compounds in the medical device until released and positioned. In addition, devices used to release implantable medical devices may be modified to reduce the potential for damage to the implantable medical device during development. In addition, various polymer combinations may be used to control the elution rates of drugs, agents and / or therapeutic compounds of implantable medical devices. |
priorityDate | 2007-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 742.